{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:18:45Z","timestamp":1762503525884},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>OBJECTIVE:<\/jats:title>\n                  <jats:p>Previously, we reported a good clinical treatment effect of intrathecal chemotherapy by repeated bolus administration of 5-fluoro-2\u2032-deoxyuridine (FdUrd) for neoplastic meningitis (NM). Moreover, we detected no side effects or neurotoxicity despite the long-term repetition of intrathecal administration. On the basis of these findings, continuous intrathecal chemotherapy (CIC) with FdUrd for patients with NM was attempted using a simple pump system. We evaluated the usefulness of CIC with FdUrd for the treatment of NM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>A total of 25 patients were enrolled in this study. FdUrd (1.0 mg\/d) was administered using a balloon pump system. CIC was continued as long as possible. Eight patients received whole-brain irradiation (3 Gy \u00d7 10) simultaneously with CIC. The effects of the treatment were analyzed in terms of improvement in neurological signs and symptoms and the findings of ventricular and lumbar cerebrospinal fluid analysis 2 and 4 weeks after CIC was initiated and on magnetic resonance imaging scans 2 months after CIC began.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>No apparent toxicity has been observed to date. Evidence of a cerebrospinal fluid response was observed in 13 patients. Headache and nausea were improved in all patients, and cranial nerve impairment was improved in 12 patients. A magnetic resonance imaging response was observed in only 5 patients. Overall response was observed in 15 patients when cases of stable disease were excluded from the responding cases. Survival time from the commencement of CIC (mean \u00b1 standard error of the mean) was 255 \u00b1 30 days in 25 patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSION:<\/jats:title>\n                  <jats:p>This therapy may be useful, especially as a maintenance therapy for NM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1227\/01.neu.0000166543.45294.f6","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T08:13:16Z","timestamp":1123488796000},"page":"266-280","source":"Crossref","is-referenced-by-count":17,"title":["Continuous Intrathecal Administration of 5-Fluoro-2\u2032-deoxyuridine for the Treatment of Neoplastic Meningitis"],"prefix":"10.1227","volume":"57","author":[{"given":"Hidemitsu","family":"Nakagawa","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Miyahara","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohichi","family":"Wada","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Tamura","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Fukushima","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"2020022704213826500_R1-11","first-page":"6079","article-title":"Intrathecal 6-mercaptopurine: Preclinical pharmacology, phase I\/II trial and pharmacokinetic study","volume":"51","author":"Adamson","year":"1991","journal-title":"Cancer Res"},{"key":"2020022704213826500_R2-11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00163704","article-title":"Intrathecal ACNU: A new therapeutic approach against malignant leptomeningeal tumors","volume":"6","author":"Arita","year":"1988","journal-title":"J Neurooncol"},{"key":"2020022704213826500_R3-11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/blood.V42.3.349.349","article-title":"Comparison of two methods of preventing central nervous system leukemia","volume":"42","author":"Aur","year":"1973","journal-title":"Blood"},{"key":"2020022704213826500_R4-11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.1992.10.1.143","article-title":"Phase I\/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies","volume":"10","author":"Berg","year":"1992","journal-title":"J Clin Oncol"},{"key":"2020022704213826500_R5-11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1005944622003","article-title":"New cytotoxic drugs for intrathecal administration","volume":"38","author":"Blaney","year":"1998","journal-title":"J Neurooncol"},{"key":"2020022704213826500_R6-11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.2003.04.053","article-title":"Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis","volume":"21","author":"Blaney","year":"2003","journal-title":"J Clin Oncol"},{"key":"2020022704213826500_R7-11","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO;2-M","article-title":"Meningeal carcinomatosis in breast cancer: Prognostic factors and influence of treatment","volume":"67","author":"Boogerd","year":"1991","journal-title":"Cancer"},{"key":"2020022704213826500_R8-11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1005996606073","article-title":"Treatment of neoplastic meningitis by targeted radiation using 131I-radiolabelled monoclonal antibodies: Results of responses and long term follow-up in 40 patients","volume":"38","author":"Coakham","year":"1998","journal-title":"J Neurooncol"},{"key":"2020022704213826500_R9-11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1020200317464","article-title":"Current options for the treatment of neoplastic meningitis","volume":"60","author":"Cokgor","year":"2002","journal-title":"J Neurooncol"},{"key":"2020022704213826500_R10-11","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/cncr.11449","article-title":"Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis","volume":"97","author":"Cole","year":"2003","journal-title":"Cancer"},{"key":"2020022704213826500_R11-11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(19950715)76:2<232::AID-CNCR2820760212>3.0.CO;2-0","article-title":"Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel","volume":"76","author":"Freilich","year":"1995","journal-title":"Cancer"},{"key":"2020022704213826500_R12-11","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/1097-0142(197604)37:4<1663::AID-CNCR2820370408>3.0.CO;2-7","article-title":"Paraplegia following intrathecal methotrexate: Report a case and review of the literature","volume":"37","author":"Gagliano","year":"1976","journal-title":"Cancer"},{"key":"2020022704213826500_R13-11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JCO.1986.4.1.68","article-title":"Combination intraventricular chemotherapy for meningeal neoplasia","volume":"4","author":"Giannone","year":"1986","journal-title":"J Clin Oncol"},{"key":"2020022704213826500_R14-11","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","article-title":"High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: Is intrathecal chemotherapy necessary?","volume":"16","author":"Glantz","year":"1998","journal-title":"J Clin Oncol"},{"key":"2020022704213826500_R15-11","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2020022704213826500_R16-11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","article-title":"Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis","volume":"11","author":"Grossman","year":"1993","journal-title":"J Clin Oncol"},{"key":"2020022704213826500_R17-11","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","article-title":"A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis","volume":"5","author":"Hitchins","year":"1987","journal-title":"J Clin Oncol"},{"key":"2020022704213826500_R18-11","first-page":"50","article-title":"Identification of therapeutic plasma FUDR concentration during continuous infusion of individually determined maximum tolerated doses","volume":"2","author":"Hrushesky","year":"1999","journal-title":"Cancer Ther"},{"key":"2020022704213826500_R19-11","first-page":"1596","article-title":"Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoam","volume":"53","author":"Kim","year":"1993","journal-title":"Cancer Res"},{"key":"2020022704213826500_R20-11","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00006123-199711000-00005","article-title":"Intraventricular immunotoxin for leptomeningeal neoplasia","volume":"41","author":"Laske","year":"1997","journal-title":"Neurosurgery"},{"key":"2020022704213826500_R21-11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0090-3019(95)00403-3","article-title":"Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis: A pilot study in 13 patients","volume":"45","author":"Nakagawa","year":"1996","journal-title":"Surg Neurol"},{"key":"2020022704213826500_R22-11","unstructured":"Nakagawa\n              H\n            , FukushimaY, TamuraM, YoshiokaK, IthoK\n          Intrathecal or intracavitary administration of sodium butyrate to treat neoplastic meningitis and malignant glioma. Presented at the 95th Annual Meeting of American Association for Cancer Research, Orlando, Florida, March 27\u201331, 2004."},{"key":"2020022704213826500_R23-11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/jjco\/hye055","article-title":"Intracavitary chemotherapy with 5-fluoro-2\u2032-deoxyuridine (FdUrd) in malignant brain tumors","volume":"31","author":"Nakagawa","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"2020022704213826500_R24-11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s002800050891","article-title":"Intrathecal 5-fluoro-2\u2032-deoxyuridine (FdUrd) for the treatment of solid tumor neoplastic meningitis: An in vivo study","volume":"43","author":"Nakagawa","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"2020022704213826500_R25-11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1006373905428","article-title":"Clinical trial of intrathecal administration of 5-fluoro- 2\u2032-deoxyuridine for treatment of meningeal dissemination of malignant tumors","volume":"45","author":"Nakagawa","year":"1999","journal-title":"J Neurooncol"},{"key":"2020022704213826500_R26-11","first-page":"238","article-title":"Cerebral effects of folic acid, pyrimidines, amino acids and their antimetabolites","volume":"12","author":"Noell","year":"1960","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"2020022704213826500_R27-11","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/1097-0142(197911)44:5<1885::AID-CNCR2820440550>3.0.CO;2-F","article-title":"CNS metastases in small cell bronchogenic carcinoma: Increasing frequency and changing pattern with lengthening survival","volume":"44","author":"Nugent","year":"1979","journal-title":"Cancer"},{"key":"2020022704213826500_R28-11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/hum.1995.6.1-55","article-title":"Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis: GTI0108\u2014A phase I\/II study","volume":"6","author":"Oldfield","year":"1995","journal-title":"Hum Gene Ther"},{"key":"2020022704213826500_R29-11","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1212\/WNL.33.12.1565","article-title":"Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma","volume":"33","author":"Ongerboer de Visser","year":"1983","journal-title":"Neurology"},{"key":"2020022704213826500_R30-11","first-page":"127","article-title":"Neurotoxicities of current leukemia therapy","volume":"1","author":"Pizzo","year":"1979","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"2020022704213826500_R31-11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/1097-0142(197502)35:2<306::AID-CNCR2820350203>3.0.CO;2-J","article-title":"The central nervous system in childhood leukemia: Part II\u2014Subacute leukoencephalopathy","volume":"35","author":"Price","year":"1975","journal-title":"Cancer"},{"key":"2020022704213826500_R32-11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00005792-198201000-00005","article-title":"Carcinomatous leptomeningitis in small cell lung cancer: A clinicopathologic review of the National Cancer Institute experience","volume":"61","author":"Rosen","year":"1982","journal-title":"Medicine (Baltimore)"},{"key":"2020022704213826500_R33-11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02327385","article-title":"Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastases: A Southwest Oncology Group Study","volume":"6","author":"Sause","year":"1988","journal-title":"J Neurooncol"},{"key":"2020022704213826500_R34-11","first-page":"733","article-title":"Treatment of meningeal neoplasms","volume":"61","author":"Shapiro","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"2020022704213826500_R35-11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","article-title":"Diagnosis and treatment of leptomeningeal metastases from solid tumor: Experience with 90 patients","volume":"49","author":"Wasserstrom","year":"1982","journal-title":"Cancer"},{"key":"2020022704213826500_R36-11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1005869226496","article-title":"In vitro study on intrathecal use of 5-fluoro-2\u2032-deoxyuridine (FdUrd) for meningeal dissemination of malignant brain tumors","volume":"37","author":"Yamada","year":"1998","journal-title":"J Neurooncol"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/57\/2\/266\/32571445\/00006123-200508000-00011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/57\/2\/266\/32571445\/00006123-200508000-00011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T17:26:39Z","timestamp":1668101199000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.lww.com\/10.1227\/01.NEU.0000166543.45294.F6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,1]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8,1]]}},"URL":"https:\/\/doi.org\/10.1227\/01.neu.0000166543.45294.f6","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,8]]},"published":{"date-parts":[[2005,8,1]]}}}